Quest Magazine

15,000 Welcome Teen MDA Ambassadors To DECA International Career Development Conference

MDA Scientific Conference Blog: Giving Our All

MDA Scientific Conference To Focus on Therapy Development for Neuromuscular Diseases

MDA Scientific Conference Blog: Stirring the Pot

Joan Jett And The Blackhearts To Headline MDA Ride For Life XXVI

ALS Research Briefs: Role of Astrocytes in ALS

Scientists continue to work at uncovering the biological mechanisms underlying amyotrophic lateral sclerosis (ALS). One area of intense study involves the potential role of central nervous system support cells called astrocytes. 

Government Funding for NMD Research Largely Spared in Continuing Resolution

The news is generally favorable for many important government-funded neuromuscular disease research projects, in the wake of Congress’ recent passage of a continuing resolution funding the government through the end of September. 

Most government operations, except those funded through the full-year appropriations bills, will be maintained at essentially the same level as fiscal year (FY) 2012. (The government's fiscal year begins on Oct. 1 and ends on Sept. 30 of the following year.)

MDA and ALSA Urge FDA to Take Action on Groundbreaking ALS Hearing

The Muscular Dystrophy Association and The ALS Association (ALSA) submitted a joint comment to the U.S. Food and Drug Administration (FDA) today, commending and thanking the agency for convening its first-ever ALS public hearing on Feb.

SMA Antisense Drug Shows Safety, Tolerability in Phase 1 Trial

An experimental drug designed to treat the underlying molecular defect in spinal muscular atrophy (SMA) has shown encouraging results in a phase 1 trial.

DMD, BMD: Combining Gene Therapy and Stem Cell Transplantation

A therapeutic strategy that combines gene therapy and stem cell transplantation has shown encouraging results in mice with a disorder mimicking Duchenne muscular dystrophy (DMD).

Pages

MDA in Your Community